Overview

A Study of 1592U89 in HIV-Infected Adults

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to see if it is safe and effective to give 1592U89 to HIV-positive adults. This study also examines the influence previous anti-HIV treatment has on the effectiveness of 1592U89.

Phase:

N/A

Details

Lead Sponsor:

Glaxo Wellcome

Treatments:

Abacavir